The article highlights the advantages of partnering with smaller outsourcing firms for small and emerging biotech companies. It argues that these smaller partners often offer personalized attention, high-quality expertise, and cost-effective solutions, which can be more beneficial than the impersonal services provided by larger CROs. The piece stresses the value of selecting a partner that aligns closely with the specific needs and goals of a biotech company.
